Di Donna Mariano Catello, Cucinella Giuseppe, Giallombardo Vincenzo, Sozzi Giulio, Bizzarri Nicolò, Scambia Giovanni, Pecorino Basilio, Scollo Paolo, Berretta Roberto, Capozzi Vito Andrea, Laganà Antonio Simone, Chiantera Vito
Unit of Gynecologic Oncology, ARNAS "Civico-Di Cristina-Benfratelli", 90127 Palermo, Italy.
Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, 90133 Palermo, Italy.
Cancers (Basel). 2023 Dec 7;15(24):5734. doi: 10.3390/cancers15245734.
Different strategies have been proposed for the treatment of locally advanced cervical cancer (LACC), with different impacts on patient's quality of life (QoL). This study aimed to analyze urinary, bowel, and sexual dysfunctions in a series of LACC patients who underwent chemotherapy, radiotherapy, radical surgery, or a combination of these treatments.
Patients with LACC who underwent neoadjuvant radio-chemotherapy (NART/CT; = 35), neoadjuvant chemotherapy (NACT; = 17), exclusive radio-chemotherapy (ERT/CT; = 28), or upfront surgery (UPS; = 10) from November 2010 to September 2019 were identified from five oncological referral centers. A customized questionnaire was used for the valuation of urinary, gastrointestinal, and sexual dysfunctions.
A total of 90 patients were included. Increased urinary frequency (>8 times/day) was higher in ERT/CT compared with NACT/RT (57.1% vs. 28.6%; = 0.02) and NACT (57.1% vs. 17.6%; = 0.01). The use of sanitary pads for urinary leakage was higher in ERT/CT compared with NACT/RT (42.9% vs. 14.3%; = 0.01) and NACT (42.9% vs. 11.8%; = 0.03). The rate of reduced evacuations (<3 times a week) was less in UPS compared with NACT/RT (50% vs. 97.1%; < 0.01), NACT (50% vs. 88.2, < 0.01), and ERT/CT (50% vs. 96.4%; < 0.01). A total of 52 women were not sexually active after therapy, and pain was the principal reason for the avoidance of sexual activity.
The rate and severity of urinary, gastrointestinal, and sexual dysfunction were similar in the four groups of treatment. Nevertheless, ERT/CT was associated with worse sexual and urinary outcomes.
针对局部晚期宫颈癌(LACC)的治疗,已提出了不同的策略,对患者生活质量(QoL)的影响各异。本研究旨在分析一系列接受化疗、放疗、根治性手术或这些治疗联合方案的LACC患者的泌尿、肠道及性功能障碍情况。
从五个肿瘤转诊中心确定了2010年11月至2019年9月期间接受新辅助放化疗(NART/CT;n = 35)、新辅助化疗(NACT;n = 17)、单纯放化疗(ERT/CT;n = 28)或 upfront手术(UPS;n = 10)的LACC患者。使用定制问卷评估泌尿、胃肠道及性功能障碍情况。
共纳入90例患者。与NACT/RT(57.1%对28.6%;P = 0.02)和NACT(57.1%对17.6%;P = 0.01)相比,ERT/CT组尿频增加(>8次/天)的发生率更高。与NACT/RT(42.9%对14.3%;P = 0.01)和NACT(42.9%对11.8%;P = 0.03)相比,ERT/CT组因尿失禁使用卫生巾的情况更多。与NACT/RT(50%对97.1%;P < 0.01)、NACT(50%对88.2%,P < 0.01)和ERT/CT(50%对96.4%;P < 0.01)相比,UPS组排便次数减少(<3次/周)的发生率更低。共有52名女性在治疗后无性生活,疼痛是避免性生活的主要原因。
四组治疗中泌尿、胃肠道及性功能障碍的发生率和严重程度相似。然而,ERT/CT与更差的性及泌尿结局相关。